C71T
CANCELLED SECTION 71
16/01/2026
Voltar para busca
Dado oficial do USPTO
ALLTAQ
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
10/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
13/10/2017
Data de registro
02/07/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/01/2026
Última transação
10/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
27
Localização do titular
DE
Examinador
KING, LINDA M
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Qiagen GmbH
Representantes
Randolph E. Digges, III Rankin, Hill & Clark LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiochemical and biotechnological diagnostic preparations used in sciencenon-medical reagentsenzymes and chemicalsbuffer solutions used in analytical chemistryfor scientific and/or medical research use for markingseparatingisolatingpurifyingamplifyingcloningsequencing and/or for the analysis of biopolymersin particular nucleic acidsin particular reagentsenzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use for markingseparatingisolatingpurifyingamplifyingcloningsequencing and/or for the analysis of biopolymersin particular nucleic acidsin particular comprising reagentsenzymes and buffer solutions for nucleic acid amplification and cloning
Classe 5
Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; Diagnostic preparations for medical and veterinary purposesdiagnostics preparations for markingseparatingisolatingpurifyingamplifyingcloningsequencing and/or for the analysis of biopolymersnucleic acids; diagnostic reagentsenzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemicalbiochemical and biotechnological diagnostic preparations for medical and veterinary purposesreagentsenzymes and buffer solutions for markingseparatingisolatingpurifyingamplifyingcloningsequencing and/or for the analysis of biopolymersnucleic acids; Diagnostic kits containing preparations for medical and veterinary diagnostic purposesfor markingseparatingisolatingpurifyingamplifyingcloningsequencing and/or for the analysis of biopolymersnucleic acids; Diagnostic kits containing reagentsenzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/07/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/12/2020
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
13/03/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
24/01/2020
RFNT
REFUSAL PROCESSED BY IB
20/12/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/11/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/10/2019
FIMP
FINAL DISPOSITION PROCESSED
19/10/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
02/07/2019
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
17/06/2019
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
23/05/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/05/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
22/03/2019
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
11/12/2018
CHPN
POST PUBLICATION AMENDMENT – NOT ENTERED
27/11/2018
GPNX
NOTIFICATION PROCESSED BY IB
24/11/2018
APET
ASSIGNED TO PETITION STAFF
20/11/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/11/2018
PUBO
PUBLISHED FOR OPPOSITION
13/11/2018
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
29/10/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/10/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
24/10/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/10/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/09/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/09/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/09/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/09/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/09/2018
RFNT
REFUSAL PROCESSED BY IB
06/04/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/03/2018
RFRR
REFUSAL PROCESSED BY MPU
19/03/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/03/2018
CNRT
NON-FINAL ACTION WRITTEN
12/03/2018
MAFR
APPLICATION FILING RECEIPT MAILED
09/03/2018
DOCK
ASSIGNED TO EXAMINER
05/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/03/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/03/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALLTAQ ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.